Clinical Report: Spondyloarthritis function varies by sex
Overview
The REGISPON-3 study reveals that women with spondyloarthritis experience greater functional deterioration compared to men, despite similar rates of permanent work disability.
Background
Spondyloarthritis is an inflammatory disorder that affects both men and women, yet previous research has often overlooked sex-related differences in disease impact. The REGISPON-3 study provides insights into how functional deterioration varies by sex over a long-term follow-up period.
Data Highlights
| Group | Mean BASFI | Change in BASFI | Permanent Work Disability |
|---|---|---|---|
| Women | 4.7 | 1.4 | 27% |
| Men | 3.6 | 0.3 | 32% |
Key Findings
- Women showed greater long-term functional deterioration than men, with higher mean BASFI scores at follow-up.
- Permanent work disability rates were similar between sexes, at 27% for women and 32% for men.
- Higher baseline BASDAI and BASRI scores were associated with permanent disability in both sexes.
- Functional change was influenced by different factors in men and women, with specific associations identified for each sex.
- The indirect effect of biologic DMARD exposure on functional change through C-reactive protein was significant in men but not in women.
Clinical Implications
Clinicians should be aware of the differing functional outcomes in spondyloarthritis based on sex.
Conclusion
The findings from the REGISPON-3 study indicate the need for considerations in the evaluation and management of spondyloarthritis based on sex.
Related Resources & Content
- Arthritis Care & Research, 2026 -- Sex Differences in Medication Discontinuation in Axial Spondyloarthritis
- Clinical Rheumatology, 2022 -- The Role of Gender and Sex in Diagnosis, Treatment Outcomes, and Health-Related Quality of Life for Patients with Axial Spondyloarthritis
- Clinical Rheumatology, 2026 -- Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?
- ACR Guidelines Advance Axial Spondyloarthritis Treatment, American College of Rheumatology, 2026
- Sex differences in long-term functional deterioration and permanent disability in spondyloarthritis: a 17-year follow-up from the REGISPON-3 study - PMC
- Frontiers in Immunology — Sex-specific COX-2/CREB/ER signaling underlies male susceptibility to pulmonary fibrosis in rheumatoid arthritis-associated interstitial lung disease
- Sex‐Related Differences in Efficacy and Safety Outcomes in Axial Spondyloarthritis Randomized Clinical Trials: A Systematic Literature Review and Meta‐Analysis
- ACR Guidelines Advance Axial Spondyloarthritis Treatment | American College of Rheumatology
- Sex differences in long-term functional deterioration and permanent disability in spondyloarthritis: a 17-year follow-up from the REGISPON-3 study - PMC
- Domains to Be Considered for the Core Outcome Set of Axial Spondyloarthritis: Results From a 3-round Delphi Survey
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
